Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia

S Kasper, MN Lerman, RD McQuade… - International Journal …, 2003 - academic.oup.com
Aripiprazole is a novel atypical antipsychotic for the treatment of schizophrenia. It is a D2
receptor partial agonist with partial agonist activity at 5-HT1A receptors and antagonist …
被引用次数：462 相关文章

Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia

S Kasper, MN Lerman, RD McQuade, A Saha… - International Journal of …, 2003 - elibrary.ru
Aripiprazole is a novel atypical antipsychotic for the treatment of schizophrenia. It is a D 2
receptor partial agonist with partial agonist activity at 5-HT 1A receptors and antagonist …

Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia.

S Kasper, MN Lerman, RD McQuade… - International …, 2003 - search.ebscohost.com
Aripiprazole is a novel atypical antipsychotic for the treatment of schizophrenia. It is a D<
sub> 2 receptor partial agonist with partial agonist activity at 5-HT< sub> 1A receptors and …

Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia.

S Kasper, MN Lerman, RD McQuade… - The International …, 2003 - europepmc.org
Aripiprazole is a novel atypical antipsychotic for the treatment of schizophrenia. It is a D2
receptor partial agonist with partial agonist activity at 5-HT1A receptors and antagonist …

Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia

S Kasper, MN Lerman, RD McQuade… - The International …, 2003 - search.proquest.com
Aripiprazole is a novel atypical antipsychotic for the treatment of schizophrenia. It is a D2
receptor partial agonist with partial agonist activity at 5-HT1A receptors and antagonist …
[PDF] academia.edu

[PDF][PDF] Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia

S Kasper, MN Lerman, RD McQuade, A Saha… - academia.edu
Aripiprazole is a novel atypical antipsychotic for the treatment of schizophrenia. It is a D2
receptor partial agonist with partial agonist activity at 5-HT1A receptors and antagonist …

Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia

S Kasper, MN Lerman, RD McQuade… - The international …, 2003 - pubmed.ncbi.nlm.nih.gov
Aripiprazole is a novel atypical antipsychotic for the treatment of schizophrenia. It is a D2
receptor partial agonist with partial agonist activity at 5-HT1A receptors and antagonist …

[引用][C] Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia

S Kasper, MN Lerman, RD McQuade, A Saha… - … International Journal of …, 2003 - cir.nii.ac.jp
Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment
following acute relapse of schizophrenia | CiNii Research CiNii 国立情報学研究所 学術情報 …
[PDF] researchgate.net

[PDF][PDF] Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia

S Kasper, MN Lerman, RD McQuade, A Saha… - researchgate.net
Aripiprazole is a novel atypical antipsychotic for the treatment of schizophrenia. It is a D2
receptor partial agonist with partial agonist activity at 5-HT1A receptors and antagonist …

Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia.

S Kasper, MN Lerman, RD McQuade… - International Journal …, 2003 - psycnet.apa.org
Aripiprazole is a novel atypical antipsychotic for the treatment of schizophrenia. It is a D₂
receptor partial agonist with partial agonist activity at 5-HT 1A receptors and antagonist …